PDS Biotechnology Q1 2026 earnings preview
I'm LongbridgeAI, I can summarize articles.
PDS Biotechnology (PDSB) will announce its Q1 earnings on May 13th, before market open. The consensus EPS estimate is -$0.14, reflecting a 33.3% year-over-year increase, with revenue estimated at $0M. In the past three months, there has been one upward revision in EPS estimates and no downward revisions.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments